SCHEMBL9821115

SCHEMBL9821115

C1CCC2C[N]CC2CC1

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
NOS1 P29475 2/20 0.35
NOS2 P35228 2/20 0.35
NOS3 P29474 1/20 0.35
OPRK1 P41145 1/20 0.31
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL240836 0.96
SCHEMBL9046191 0.96
SCHEMBL9048889 0.96
SCHEMBL9049423 0.89
SCHEMBL45684 0.89
SCHEMBL7844516 0.82 ALDH1A1 (0.44) ALDH1A1NOS1NOS2NOS3
SCHEMBL5379768 0.82 ALDH1A1 (0.44) ALDH1A1NOS1NOS2NOS3
SCHEMBL7853346 0.82 ALDH1A1 (0.44) ALDH1A1NOS1NOS2NOS3
SCHEMBL5652391 0.82 ALDH1A1 (0.44) ALDH1A1NOS1NOS2NOS3
SCHEMBL1366434 0.82 ALDH1A1 (0.44) ALDH1A1NOS1NOS2NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4820695-A GRAMNEGATIVE BACTERIA ELI LILLY AND COMPANY (US) 1989-04-11 US claimed
EP-0124216-B1 C-20- AND C-23-MODIFIED MACROLIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1988-10-26 EP claimed
EP-0103465-B1 20-AMINO MACROLIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1986-09-10 EP claimed
EP-0124216-A1 C-20- and C-23-modified macrolide derivatives ELI LILLY AND COMPANY (US) 1984-11-07 EP claimed
US-4468511-A C-20- And C-23-Modified macrolide derivatives ELI LILLY AND COMPANY (US) 1984-08-28 US claimed
EP-0103465-A1 20-Amino macrolide derivatives ELI LILLY AND COMPANY (US) 1984-03-21 EP claimed
EP-0240264-B1 IMPROVED PROCESS FOR PREPARING MACROLIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1991-08-28 EP disclosed
US-4921947-A Process for preparing macrolide derivatives ELI LILLY AND COMPANY (US) 1990-05-01 US disclosed
US-4920103-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1990-04-24 US disclosed
EP-0188373-B1 MACROLIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1989-11-08 EP disclosed
US-4820694-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1989-04-11 US disclosed
US-4820695-A GRAMNEGATIVE BACTERIA ELI LILLY AND COMPANY (US) 1989-04-11 US disclosed
EP-0124216-B1 C-20- AND C-23-MODIFIED MACROLIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1988-10-26 EP disclosed
EP-0188373-A2 Macrolide derivatives ELI LILLY AND COMPANY (US) 1986-07-23 EP disclosed
EP-0124216-A1 C-20- and C-23-modified macrolide derivatives ELI LILLY AND COMPANY (US) 1984-11-07 EP disclosed
US-4468511-A C-20- And C-23-Modified macrolide derivatives ELI LILLY AND COMPANY (US) 1984-08-28 US disclosed
EP-0103465-A1 20-Amino macrolide derivatives ELI LILLY AND COMPANY (US) 1984-03-21 EP disclosed
US-4353826-A ANTITUBERCULAR ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1982-10-12 US disclosed
US-4261891-A BACTERICIDES, ANTITUBERCULAR AGENTS CIBA-GEIGY CORPORATION (US) 1981-04-14 US disclosed
US-4005077-A DERIVATIVES OF RIFAMYCIN S OR SV CIBA-GEIGY CORPORATION (US) 1977-01-25 US disclosed